Ascletis Pharma (2VJ.STU) Q3 2026 Earnings

24AugConfirmed
Q1 2026
-0.03
0.3
0.63
0.97

Details

Expected EPS
-0.02502210516
Actual EPS
N/A
Surprise EPS
0.03
Surprise Percent
+100%

Description

Ascletis Pharma (2VJ.STU) will report earnings of for Q3 2026 on August 24, 2026.

0 Comments

Share your thoughts